Olema Pharmaceuticals, Inc. (OLMA)

6d ago, source: Yahoo Finance

SAN FRANCISCO, April 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical ...

How Olema Oncology moved from layoffs to pivotal cancer drug studies

16d ago, source: The Business Journals

Olema Pharmaceuticals Inc.'s cash had dropped below $200 million, and the San Francisco drug developer (NASDAQ: OLMA) needed to funnel all the money it could toward its best bets, specifically its ...

Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

1mon ago, source: Business Insider

Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted ...

Buy Rating on Olema Pharmaceuticals Amidst Promising Oncology Developments and Competitive Edge

13d ago, source:

Analyst Naureen Quibria from Capital One Financial reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) and keeping ...

Olema Pharmaceuticals inc Ordinary Shares

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23d ago, source: Stockhouse

SAN FRANCISCO, April 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage ...

OLMA Olema Pharmaceuticals, Inc.

7d ago, source: Seeking Alpha

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate ...

OLMA Olema Pharmaceuticals, Inc.

9d ago, source: Seeking Alpha

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate ...

Olema Pharmaceuticals Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...